Detects mutations within exons 14 and 17 of the CSF3R gene in blood cells.
Used alongside blood counts, bone-marrow findings and other laboratory tests to support the diagnosis and classification of chronic neutrophilic leukaemia and related myeloid neoplasms. It is not a general inherited-cancer screening test.